RE:RE:RE:Lets clear up some confusion 25 March THRM reported receiving ethics approval for clinical study. They proceeded in Brazil. 22 April SONA received ethics approval for clinical study which they'll do in Toronto. The wording of the two releases is different. To me this puts SONA almost a month behind, plus this didn't indicate they are testing for variants which THRM has already done. I think we're in a good position. You can get 3 to 1 shares if people in sona flip over here which means a potentially much larger return. I'm more confident in THRM.